English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

SUMMARY OBJECTIVE: To demostrate that human immunodeficiency virus (HIV) patients in acquired immunodeficiency syndrome (AIDS) phase associated with tuberculosis (TB) or cryptococcosis have hypomagnesemia-related inadequate treatment response. DESIGN: Prospective and longitudinal study. MATERIALS AND METHODS: We studied 300 subjects, divided in six groups of 50 patients each: positive HIV patients, TB patients, AIDS patients with TB, AIDS patients with cryptococcosis, no-AIDS patients with acute infections and a normal group (blood donors). RESULTS: Average magnesium values were below normal in the groups AIDS/TB, AIDS/cryptococcosis and TB. There were important statistical differences in magnesium levels in the groups HIV, AIDS/TB, AIDS/ cryptococcosis and TB. With respect to hypomagnesemia, the group with less response to treatment was the AIDS+TB (27%). CONCLUSIONS: Hypomagnesemia is prevalent in chronic infectious diseases with important differences in magnesium levels among the four groups studied and AIDS/TB group showing more abnormalities.

Niveles de magnesio en pacientes VIH estadio SIDA, que cursan con tuberculosis, criptococosis, y su relación con la respuesta al tratamiento